Do DMARDs and biologic agents protect from cardiovascular disease in patients with inflammatory arthropathies?

Fabiola Atzeni; Elisabet Svenungsson; Michael T Nurmohamed

doi:10.1016/j.autrev.2019.102401

Do DMARDs and biologic agents protect from cardiovascular disease in patients with inflammatory arthropathies?

Autoimmun Rev. 2019 Dec;18(12):102401. doi: 10.1016/j.autrev.2019.102401. Epub 2019 Oct 23.

Authors

Fabiola Atzeni¹, Elisabet Svenungsson², Michael T Nurmohamed³

Affiliations

¹ Rheumatology Unit, University of Messina, Messina, Italy.
² Department of Medicine, Division of Rheumatology, Karolinska Institutet, Karolinska University Hospital, Stockholm 171 72, Sweden. Electronic address: elisabet.svenungsson@ki.se.
³ Amsterdam Rheumatology immunology Center, Amsterdam University Medical Center- Location VUmc* & Reade Rheumatology**, Amsterdam, The Netherlands.

PMID: 31655302
DOI: 10.1016/j.autrev.2019.102401

No abstract available

Keywords: Biologic treatment; Cardiovascular disease; Disease modifying antirheumatic drugs (DMARDS); Inflammatory arthropathies; Rheumatoid arthritis.

Publication types

Review

MeSH terms

Antirheumatic Agents / therapeutic use*
Arthritis, Rheumatoid*
Biological Factors / therapeutic use*
Cardiovascular Diseases / prevention & control*
Humans

Substances

Antirheumatic Agents
Biological Factors